Boothbay Fund Management, LLC Hepion Pharmaceuticals, Inc. Transaction History

Boothbay Fund Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.57 - $1.22 $5,979 - $12,799	-10,491 Reduced 18.87%	45,108 $26,000
Q3 2021 Nov 15, 2021	SELL	$1.39 - $2.1 $138,263 - $208,887	-99,470 Reduced 64.15%	55,599 $85,000
Q2 2021 Aug 16, 2021	BUY	$1.56 - $2.26 $241,907 - $350,455	155,069 New	155,069 $307,000

Ticker HEPA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,229,600
Market Cap $57.2M
Description
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.